Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.

F, Cosentino; CP, Cannon; DZI, Cherney; U, Masiukiewicz; R, Pratley; S, Dagogo-Jack; R, Frederich; B, Charbonnel; J, Mancuso; WJ, Shih; SG, Terra; NB, Cater; I, Gantz; DK, McGuire

doi:10.1161/circulationaha.120.050255

Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial. | NobleBlocks